Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa : A Prospective Cohort Study
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
This prospective cohort study of 622 women living with human immunodeficiency virus (HIV) from Johannesburg (2012) detected Mycoplasma genitalium in 7.4% (95% confidence interval [CI]: 5.5-9.7, 46/622), with detection more likely with lower CD4 counts(adjusted odds ratio [AOR] 1.02 per 10 cells/μL decrease, 95% CI: 1.00-1.03) and higher plasma HIV-1 RNA (AOR 1.15 per log copies/mL increase, 95% CI: 1.03-1.27). No mutations for macrolide/quinolone resistance was detected.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 69(2019), 5 vom: 16. Aug., Seite 873-876 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ong, Jason J [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 17.09.2020 Date Revised 17.09.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/cid/ciz045 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM293256500 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM293256500 | ||
003 | DE-627 | ||
005 | 20231225074926.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciz045 |2 doi | |
028 | 5 | 2 | |a pubmed24n0977.xml |
035 | |a (DE-627)NLM293256500 | ||
035 | |a (NLM)30698679 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ong, Jason J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa |b A Prospective Cohort Study |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.09.2020 | ||
500 | |a Date Revised 17.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a This prospective cohort study of 622 women living with human immunodeficiency virus (HIV) from Johannesburg (2012) detected Mycoplasma genitalium in 7.4% (95% confidence interval [CI]: 5.5-9.7, 46/622), with detection more likely with lower CD4 counts(adjusted odds ratio [AOR] 1.02 per 10 cells/μL decrease, 95% CI: 1.00-1.03) and higher plasma HIV-1 RNA (AOR 1.15 per log copies/mL increase, 95% CI: 1.03-1.27). No mutations for macrolide/quinolone resistance was detected | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Mycoplasma genitalium | |
650 | 4 | |a HIV | |
650 | 4 | |a antimicrobial resistance | |
650 | 4 | |a sexually transmitted infections | |
650 | 4 | |a women | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Magooa, Mahlape Precious |e verfasserin |4 aut | |
700 | 1 | |a Chikandiwa, Admire |e verfasserin |4 aut | |
700 | 1 | |a Kelly, Helen |e verfasserin |4 aut | |
700 | 1 | |a Didelot, Marie-Noelle |e verfasserin |4 aut | |
700 | 1 | |a Muller, Etienne E |e verfasserin |4 aut | |
700 | 1 | |a Maseko, Venessa |e verfasserin |4 aut | |
700 | 1 | |a Segondy, Michel |e verfasserin |4 aut | |
700 | 1 | |a Delany-Moretlwe, Sinead |e verfasserin |4 aut | |
700 | 1 | |a Kularatne, Ranmini |e verfasserin |4 aut | |
700 | 1 | |a Mayaud, Philippe |e verfasserin |4 aut | |
700 | 0 | |a HIV in Africa Research Partnership Study Group |e verfasserin |4 aut | |
700 | 1 | |a Chikandiwa, A |e investigator |4 oth | |
700 | 1 | |a Cutler, E |e investigator |4 oth | |
700 | 1 | |a Delany-Moretlwe, S |e investigator |4 oth | |
700 | 1 | |a Lewis, D A |e investigator |4 oth | |
700 | 1 | |a Magooa, M P |e investigator |4 oth | |
700 | 1 | |a Maseko, V |e investigator |4 oth | |
700 | 1 | |a Michelow, P |e investigator |4 oth | |
700 | 1 | |a Muzah, B |e investigator |4 oth | |
700 | 1 | |a Omar, T |e investigator |4 oth | |
700 | 1 | |a Puren, A |e investigator |4 oth | |
700 | 1 | |a Djigma, F |e investigator |4 oth | |
700 | 1 | |a Drabo, J |e investigator |4 oth | |
700 | 1 | |a Goumbri-Lompo, O |e investigator |4 oth | |
700 | 1 | |a Meda, N |e investigator |4 oth | |
700 | 1 | |a Sawadogo, B |e investigator |4 oth | |
700 | 1 | |a Simporé, J |e investigator |4 oth | |
700 | 1 | |a Yonli, A |e investigator |4 oth | |
700 | 1 | |a Zan, S |e investigator |4 oth | |
700 | 1 | |a Costes, V |e investigator |4 oth | |
700 | 1 | |a Didelot, M-N |e investigator |4 oth | |
700 | 1 | |a Doutre, S |e investigator |4 oth | |
700 | 1 | |a Leventoux, N |e investigator |4 oth | |
700 | 1 | |a Nagot, N |e investigator |4 oth | |
700 | 1 | |a Ngou, J |e investigator |4 oth | |
700 | 1 | |a Segondy, M |e investigator |4 oth | |
700 | 1 | |a Devine, A |e investigator |4 oth | |
700 | 1 | |a Gilham, C |e investigator |4 oth | |
700 | 1 | |a Gibson, L |e investigator |4 oth | |
700 | 1 | |a Kelly, H |e investigator |4 oth | |
700 | 1 | |a Legood, R |e investigator |4 oth | |
700 | 1 | |a Mayaud, P |e investigator |4 oth | |
700 | 1 | |a Weiss, H A |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 69(2019), 5 vom: 16. Aug., Seite 873-876 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:69 |g year:2019 |g number:5 |g day:16 |g month:08 |g pages:873-876 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciz045 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 69 |j 2019 |e 5 |b 16 |c 08 |h 873-876 |